How has been the historical performance of Bayer CropSci.?

Nov 09 2025 10:41 PM IST
share
Share Via
Bayer CropSci. has shown increasing net sales, reaching 5,473.40 Cr in March 2025, but experienced declines in operating profit, profit before tax, and profit after tax. Despite asset growth to 5,236.20 Cr, cash flow from operating activities significantly decreased, resulting in a net cash outflow of 271.00 Cr.
Answer:
The historical performance of Bayer CropSci. shows a trend of increasing net sales and operating income over the years, with net sales reaching 5,473.40 Cr in March 2025, up from 5,106.20 Cr in March 2024 and 5,139.70 Cr in March 2023. However, operating profit (PBDIT) has seen a decline from 1,035.00 Cr in March 2024 to 809.30 Cr in March 2025. Profit before tax also decreased to 707.40 Cr in March 2025 from 941.40 Cr in March 2024, while profit after tax fell to 568.00 Cr from 740.50 Cr in the same period. The company's total assets increased to 5,236.20 Cr in March 2025, compared to 4,597.10 Cr in March 2024, indicating growth in the asset base. Total liabilities also rose to 5,236.20 Cr from 4,597.10 Cr, reflecting an increase in financial obligations. Cash flow from operating activities decreased significantly to 262.00 Cr in March 2025 from 951.00 Cr in March 2024, contributing to a net cash outflow of 271.00 Cr in March 2025.

Breakdown:
Bayer CropSci. has demonstrated a consistent increase in net sales, achieving 5,473.40 Cr in March 2025, a rise from previous years, although operating profit has declined from 1,035.00 Cr in March 2024 to 809.30 Cr in March 2025. Profit before tax and profit after tax also saw reductions, with figures of 707.40 Cr and 568.00 Cr respectively in March 2025. The total assets of the company increased to 5,236.20 Cr, indicating a growing asset base, while total liabilities rose correspondingly to the same figure, suggesting a balance between asset growth and financial obligations. The cash flow from operating activities has notably decreased to 262.00 Cr, leading to a net cash outflow of 271.00 Cr, which highlights challenges in cash generation despite the growth in sales.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Bayer CropSci. falling/rising?
Nov 11 2025 10:56 PM IST
share
Share Via
Are Bayer CropSci. latest results good or bad?
Nov 08 2025 07:19 PM IST
share
Share Via
Why is Bayer CropSci. falling/rising?
Nov 06 2025 10:45 PM IST
share
Share Via
Is Bayer CropSci. overvalued or undervalued?
Oct 20 2025 08:06 AM IST
share
Share Via
Is Bayer CropSci. overvalued or undervalued?
Oct 19 2025 08:06 AM IST
share
Share Via